BTF3P6

Across TCGA pan-cancer cohorts, BTF3P6 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated BTF3P6 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher BTF3P6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BTF3P6 expression acts as an unfavorable survival marker, although some lineages such as LUAD and CHOL show a favorable association.

COAD, KIRC, and MESO are the cancer types where BTF3P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	II,III,IV	0.765	0.895	.005	52	view →
KIRC	OS	Tertile	All	0.525	0.720	.001	46	view →
MESO	DFS	Median	III,IV	0.170	0.660	<.001	40	view →
BLCA	DFS	Quartile	II,III,IV	0.512	0.666	.011	26	view →
LGG	DFS	Quartile	All	0.634	0.773	<.001	25	view →
UVM	DFS	Tertile	II,III,IV	0.407	0.662	.016	21	view →
PAAD	OS	Median	All	0.304	0.574	.001	18	view →
OV	DFS	Median	IV	0.337	0.559	.005	16	view →
LUAD	OS	Median	II,III,IV	0.635	0.434	.011	15	view →
CHOL	OS	Median	All	0.718	0.437	.021	10	view →
READ	DFS	Quartile	IV	0.278	0.834	.024	9	view →
LIHC	DFS	Tertile	All	0.368	0.460	.020	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

BTF3P6–COAD (OS)

Open the COAD breakdown →